NextFin News - DCC Plc was reported on June 10, 2026 to be inclined to accept a new £5.7 billion bid from KKR and Energy Capital Partners, according to Bloomberg.
The report, filed by Dinesh Nair and Swetha Gopinath, said the two investors improved their approach and secured backing for the revised offer. If DCC’s board recommends the deal, it would rank among the largest UK public-to-private transactions of the year. It would also show that, despite a choppy valuation environment, buyers with long investment horizons are still prepared to pay for scale and cash flow.
DCC’s appeal is straightforward. It is not a high-growth company, but it runs a broad distribution business across energy, healthcare and technology and has a footprint that gives it recurring revenue characteristics that private equity firms often seek. Interest in a company like this usually rests less on rapid expansion than on stable margins, portfolio changes and the chance to unlock value that public markets may not fully price. For KKR and ECP, the case is that DCC’s sum-of-the-parts value, operating discipline and cash generation can support a price that remains substantial even after years of higher financing costs.
The new £5.7 billion figure shows the buyers have moved enough from their earlier position to keep talks alive. It also suggests they have not raised the offer without limits. For DCC directors, the question is whether the revised bid gives shareholders enough compensation for the certainty of cash now versus the possibility that the company can keep compounding as a listed business. For KKR and ECP, the issue is whether a higher price still leaves room to lift returns through operational changes, asset sales or tighter capital allocation after the deal closes.
That calculation is particularly sharp in the UK market. London-listed mid- and large-cap companies have traded at discounts to global peers for years, partly because domestic equity funds have shrunk and strategic buyers have stayed cautious. Private equity firms have repeatedly targeted that gap, arguing that public investors are undervaluing steady businesses with real cash flow. DCC fits that pattern. It is not a concept stock, and it is the kind of company a buyer can model with more confidence than software or biotech. That confidence usually requires a premium.
Bloomberg reported that the improved offer has changed the tone of the negotiations, but the usual risks remain. Financing terms can move, due diligence can uncover problems and shareholder expectations can harden. In a deal involving a long-established listed group, directors also have to weigh execution certainty, regulatory review and the effects on employees and operations, not just the headline price. Even if the board is prepared to recommend an offer, final documentation, governance conditions or go-shop expectations can still prolong the process.
For DCC investors, the practical question is whether the current bid values the business fairly at this point in the cycle. Distribution companies can look unexciting until the macro picture shifts and their pricing power, working-capital dynamics and geographic reach become more important. If inflation eases, rates drift lower and customer activity stabilizes, DCC could still make the case for remaining public. If the board accepts the bid, the market will quickly start treating the company as a transaction rather than an independent compounding business.
A successful acquisition of DCC would also add to a broader European dealmaking pattern. It would suggest sponsor capital remains most active where a target has scale, predictable earnings and manageable cyclicality. It would also indicate that the region’s public-market discount is still large enough to draw bidders even after higher financing costs and tougher antitrust scrutiny. The report’s wording matters: “inclined to accept” leaves room for last-minute negotiation and for directors to test whether the revised terms fully reflect the business they are handing over.
Explore more exclusive insights at nextfin.ai.
